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We have previously shown that blood global DNA methylation (DNAm) differs
between postprandial state (PS) and fasting state (FS) and is associated with BMI
and polyunsaturated fatty acid (PUFA) (negatively and positively, respectively) in 12
metabolically healthy adult Mexican men (AMM cohort) equally distributed among
conventional BMI classes. Here, we detailed those associations at CpG dinucleotide
level by exploiting the Infinium methylation EPIC array (Illumina). We sought differentially
methylated CpG (dmCpG) that were (1) associated with BMI (BMI-dmCpG) and/or fatty
acids (FA) (FA-dmCpG) in FS or PS and (2) different across FS and PS within a BMI class.
BMI-dmCpG and FA-dmCpG were more numerous in FS compared to PS and largely
prandial state-specific. For saturated and monounsaturated FA, dmCpG overlap was
higher across than within the respective saturation group. Several BMI- and FA-dmCpG
mapped to genes involved in metabolic disease and in some cases matched published
experimental data sets. Notably, SETDB1 and MTHFS promoter dmCpG could explain
the previously observed associations between global DNAm, PUFA content, and BMI
in FS. Surprisingly, overlap between BMI-dmCpG and FA-dmCpG was limited and the
respective dmCpG were differentially distributed across functional genomic elements.
BMI-dmCpG showed the highest overlap with dmCpG of the saturated FA palmitate,
monounsaturated C20:1 and PUFA C20:2. Of these, selected promoter BMI-dmCpG
showed opposite associations with palmitate compared to C20:1 and C20:2. As for
the comparison between FS and PS within BMI classes, dmCpG were strikingly more
abundant and variably methylated in overweight relative to normoweight or obese
subjects (∼70–139-fold, respectively). Overweight-associated dmCpG-hosting genes
were significantly enriched in targets for E47, SREBP1, and RREB1 transcription
factors, which are known players in obesity and lipid homeostasis, but none
overlapped with BMI-dmCpG. We show for the first time that the association of BMI
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and FA with methylation of disease-related genes is distinct in FS and PS and that
limited overlap exists between BMI- and FA-dmCpG within and across prandial states.
Our study also identifies a transcriptional regulation circuitry in overweight that might
contribute to adaptation to that condition or to transition to obesity. Further work is
necessary to define the pathophysiological implications of these findings.
Keywords: prandial state, BMI, fatty acid, DNA methylation, epigenomics
INTRODUCTION
The associations of specific DNA methylation (DNAm) profiles
with BMI, lipids, and fatty acids (FA) have been documented
by observational studies, and in some instances, causality has
been established. In the case of BMI, Mendelian randomization
approaches have been used in epigenome-wide association
studies (EWAS) to assess causality in large cohorts with complex
phenotypic stratification. Conflicting results were obtained, as
both BMI-to-DNAm and the opposite causality direction were
demonstrated (Huan et al., 2019; Sun et al., 2019; Vehmeijer
et al., 2020). As for lipid-DNAm causality, circulating lipids cause
DNAm and not vice versa (Dekkers et al., 2016). Among FA,
arachidonic (AA), oleic (OA), elaidic (EA), and palmitic acid
(PA) elicit changes in DNAm in experimental models (Barrès
et al., 2009; Hall et al., 2014; Flores-Sierra et al., 2016; Silva-
Martínez et al., 2016; González-Becerra et al., 2019). Associations
of FA with DNAm have also been uncovered in EWAS and global
DNAm studies (Aslibekyan et al., 2014; de la Rocha et al., 2016).
Despite the wealth of data on DNAm and metabolism, the
existence of rapid—i.e., within hours—effects of the diet on
DNAm in humans is little explored, particularly in the context
of obesity. It is conceivable that as part of the normal metabolic
adaptation, epigenetic profiles are dynamically reset during
fasting to postprandial conditions and that obesity may lead to a
loss of resetting ability (Longo and Mattson, 2014). Western-style
obesogenic diets might further exacerbate such loss of flexibility.
This hypothesis of transition of epigenetic profiles from flexible
in pre-obesity to fixed in obesity is conceptually similar to the
model that identifies dynamic reprogramming during embryonic
development as sensitive to environmental stimuli that can result
in the acquisition of stable phenotypic traits in later life (Kwong
et al., 2000). Therefore, insights into the epigenetic effects of
fasting/postprandial cycles might help in defining novel strategies
against obesity.
To address that issue, we previously exploited a cohort of
12 adult Mexican men (AMM cohort) distributed across the
three conventional BMI classes. This study design offered several
unique advantages. The same subjects underwent fasting (FS) and
postprandial states (PS) within a 1–2-week period, and DNAm
and individual FA content was measured within a 1–8 h time
Abbreviations: AA, arachidonic acid; AMM, adult Mexican men cohort; BMI,
body mass index; CpG, 5′-CG-3′ dinucleotide; DGLA, dihomo-γ-linolenic
acid; dmCpG, differentially methylated CpG; DNAm, DNA methylation; EA,
elaidic acid; EDA, eicosadienoic acid; FA, fatty acid; FS, fasting state; MUFA,
monounsaturated fatty acid; N, normoweight subject; OA, oleic acid; Ob, obese
subject; Ow, overweight subject; PA, palmitic acid; PS, postprandial state; PUFA,
polyunsaturated fatty acid; SFA, saturated fatty acid.
range. Thus, confounders such as genetic variants and age could
be ruled out. Furthermore, AMM was homogeneous with respect
to gender, metabolic profiles, and occupational and lifestyle-
related factors. The main finding of the original AMM study was
an inverse correlation between global DNAm and BMI that was
conserved across prandial states. Conversely, polyunsaturated
FA (PUFA) were positively associated with DNAm in both
prandial states. In particular, eicosapentaenoic acid was positively
associated with DNAm in both FS and PS, while AA only showed
a positive association with DNAm in PS (de la Rocha et al., 2016).
The present study describes CpG methylation data obtained
in the AMM cohort with the Infinium methylation EPIC
array (Illumina) (Moran et al., 2016). In particular, we identify
differentially methylated CpG (dmCpG) sites associated with
BMI and/or FA, within or across FS and PS.
MATERIALS AND METHODS
A flow diagram of the study is shown in Supplementary Figure 1.
Study Participants
The AMM cohort was previously described (de la Rocha
et al., 2016). Briefly, AMM consisted of 12 adult male subjects
equally distributed across the three conventional BMI classes,
normal weight (N), overweight (Ow), and obese (BMI bins
18.5–24.9, 25–29.9, and > 30, respectively). All participants
were metabolically healthy (normal blood glucose, triglycerides,
cholesterol, and blood pressure), lived in the city of Leon, and
were employed as janitors at the University of Guanajuato,
Mexico. On one experimental day, subjects who had undergone
overnight fasting and abstained from exercise for 48 h received
a standard Western-style meal (one each of McDonald’s
McChicken, medium-size fries, medium-size Coke) at 10 am,
immediately after a venous blood draw which was followed
by four additional draws every 2 h (postprandial state or PS).
On a different day, the same subjects underwent complete
fasting under the same blood draw scheme (fasting state or
FS). PS and FS procedures were separated by 7–14 days.
All biochemical and molecular determinations were carried
out in blood obtained from the same draw. The study was
carried out in accordance with the recommendations of the
Mexican Government guidelines (NOM-012-SSA3-2012) and
the Ethical Committee of the Department of Medical Sciences,
University of Guanajuato; the latter also approved the protocol.
All subjects gave written informed consent in accordance with
the Declaration of Helsinki.
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DNA Methylation Data
The five peripheral blood samples corresponding to each
subject were pooled, resulting in 12 samples for each
experimental day. Whole-blood DNA was profiled with the
Infinium methylation EPIC array (Illumina) according to
the manufacturer’s instructions (Moran et al., 2016). Arrays
were imaged using BeadArray Reader (Illumina HiSeq 2000)
using the standard recommended Illumina scanner setting.
The IDAT files were normalized (control normalization)
and background corrected using the methylation module
(??) available on GenomeStudio (v2011.1) software from
Illumina. Probes with the following characteristics were filtered
out: SNPs within CpG, probes, or single-base extensions
(list compiled by Pidsley et al., 2016); X or Y chromosome
probes; probes with detection p > 0.01; and those significantly
associated with age by Pearson’s or Spearman’s test depending
on the normality of distribution (see section “Statistics”).
A total of 736,741 probes passed those filters. All genomic
coordinates refer to the GRCh37/hg19 assembly. The raw
datasets generated for this study were deposited in the GEO
repository1, ID no. GSE140692.
Fatty Acid Profiles
Whole-blood total (i.e., free and bound) FA profiles were
obtained previously (de la Rocha et al., 2016) and included
the following FA: saturated (SFA): myristic (C14:0), PA and
stearic acid (C18:0); monounsaturated (MUFA): palmitoleic
acid (C16:1n-9), EA, OA, and a mix of C20:1 isomers; and
PUFA: linoleic, eicosadienoic (EDA), dihomo-γ-linolenic
(DGLA), AA, eicosapentaenoic (C20:5), docosatetraenoic
(C22:4n-6), docosapentaenoic (C22:5n-3), and docosahexaenoic
(C22:6n-3) acids. C18:3 was determined but excluded
as one or more data points could not be determined.
Throughout the text, the most widely known FA will
be referred to by acronym, the remaining FA by short
chemical annotation.
Statistics
Methylation M-values were used for statistics, while the more
intuitive β-values were used in data presentation (Du et al.,
2010). Probes with one or more missing data points were
not considered. The statistical tests applied were dependent on
whether data fitted a normal distribution as assessed by the
Shapiro–Wilk test, i.e., Pearson’s or Spearman’s test, respectively,
in correlations with BMI or FA, and paired t-test or Wilcoxon
signed-rank test, respectively, in FS versus PS comparisons.
Frequencies were compared by the Chi-square test. DNAm
was implicitly considered as the dependent variable, based on
previous biological evidence (Barrès et al., 2009; Hall et al., 2014;
de la Rocha et al., 2016; Silva-Martínez et al., 2016). FA-values
were percent normalized. P-values were corrected for blood
cell composition using the minfi package in R. Nominal (not
genome-wide corrected) p < 0.05 was considered significant.
1www.ncbi.nlm.nih.gov/geo/
Gene functional enrichment was tested with the DAVID resource
with FDR p < 0.05 as significance threshold2.
RESULTS
Prandial State-Dependent and
Independent Associations of DNAm With
BMI
We first sought to identify dmCpG associated with BMI
(BMI-CpG). To that end, we performed a correlation analysis
between CpG methylation (M-values) and BMI across N,
Ow, and Ob samples, either in FS or PS. A BMI-dmCpG
was called if average 1β > 0.10 between N and Ob and
DNAm M value correlation significance of p < 0.05. Although
carbohydrates might affect DNAm, we excluded glucose from
this and the following association analyses, as glycemia was
below the 100-mg/dL normal reference limit in all subjects.
We identified a total of 107 and 41 BMI-dmCpG in FS and
PS, respectively. Of these, 15 were conserved across prandial
states, i.e., 37 and 14% of FS and PS BMI-dmCpG, respectively
(Figure 1A and Supplementary Table 1). Notably, the 1β
of BMI-dmCpG conserved between FS and PS were highly
correlated (r = 0.996, p < 10−6), indicating high between-
array technical consistency. While a slight majority (57.9%)
of FS BMI-dmCpG was inversely associated (hypomethylated)
with BMI, hypermethylation was predominant (78.0%) of
PS BMI-dmCpG (Figure 1A and Supplementary Table 1).
That trend resembled the global DNAm trends previously
published in FS and in N relative to Ow individuals in PS
(de la Rocha et al., 2016).
No significantly enriched pathway or transcription factor
target was identified of BMI-dmCpG-harboring genes, and none
of BMI-dmCpG overlapped with those reported in EWAS of
BMI (Aslibekyan et al., 2015; Demerath et al., 2015; Dhana
et al., 2018; Geurts et al., 2018). However, two BMI-dmCpG—
cg16733226 in the CAMK1D gene body and cg21273765 in
the HIF3A distal promoter—were associated with BMI in
peripheral blood in the Strong Heart Study (Crocker et al.,
2020). Focusing on BMI-dmCpG (specific to or shared across
prandial states) that were located within promoter regions,
we identified single or clustered dmCpG within a number of
obesity and metabolism-related genes (Table 1). Examples of
the latter were the detoxification gene GSTM5 in FS and the
transcription factor ZNF718 in PS. Notably, akin to the findings
of the Strong Heart Study (Crocker et al., 2020), cg21273765
in HIF3A was positively associated with BMI. The direction of
association of promoter BMI-dmCpG was similar to the overall
trend described previously, i.e., the predominance of negative
(hypomethylated) and positive (hypermethylated) associations in
FS and PS, respectively (Table 1 and Supplementary Table 1).
Of the 15 dmCpG that were shared between FS and PS, three
were within promoter regions of the following genes: MTHFS,
which encodes an enzyme of the folate metabolism pathway;
2david.ncifcrf.gov
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FIGURE 1 | DmCpG in associations with BMI or FA. (A) Prandial state-dependent associations of DNA methylation with BMI, SFA, MUFA, and PUFA. In pie charts,
white and black indicate hypomethylated (negatively associated) and hypermethylated (positively associated) BMI-dmCpG, SFA-dmCpG, MUFA-dmCpG, and
PUFA-dmCpG sets, respectively. Hypomethylated dmCpG percentage is indicated in each pie chart. DmCpG counts are indicated above the respective pie chart.
(B) Shared dmCpG among SFA, MUFA, and PUFA. r-values show correlations between shared dmCpG across saturation groups.
TABLE 1 | Selected relevant promoter BMI-dmCpG.
Gene CpG ID r, FS r, PS Function/relevance
FS ANKLE2 cg26577667 0.81 SIRT2 pathway, nuclear envelope assembly (Kaufmann et al., 2016)
ASAH1 cg22061769 −0.83 Ceramide metabolism, NAFLD (Presa et al., 2019)
ATP13A4 cg23159337 0.70 Obesity (Biamino et al., 2016)
CCNL1 cg24725175 0.66 Genetic variants associated with leptin (Kilpeläinen et al., 2016)





HIF3A cg21273765 0.87 Hypermethylated promoter in diabetes and obesity (Zhang et al., 2019;
Crocker et al., 2020)
HOPX cg25456368 −0.65 Cardiomyocyte differentiation (Friedman et al., 2018)
cg04085076 −0.75
VEGFC cg24597353 −0.74 Obesity and insulin resistance (Tinahones et al., 2012)
PS DCLK1 cg05639937 0.67 Inflammation, epithelium repair (Yi et al., 2019)






PS and FS HOPX cg00493422 −0.78 −0.78 Adipocyte differentiation (Hng et al., 2020)
MTHFS cg04124281 0.69 0.79 Folate metabolism and purine synthesis (Anguera et al., 2003; Misselbeck
et al., 2019)
SPIRE2 cg07402062 −0.81 −0.80 Fatty acid synthase regulation (Song et al., 2020)
NAFLD, nonalcoholic fatty liver disease.
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the homeobox-binding HOPX; and SPIRE2, a player in actin
cytoskeleton dynamics and intracellular transport.
Prandial State-Dependent Associations
of DNAm With FA
Next, we sought associations between CpG methylation M-values
and FA grouped by degree of saturation, i.e., SFA, MUFA,
and PUFA. Criteria for dmCpG calling were as described
above for BMI. Ranking by total dmCpG number was
SFA≈PUFA > MUFA, and most dmCpG were prandial state-
specific, i.e., on average only 2 and 6% were conserved across
prandial states as proportions of FS and PS dmCpG, respectively
(Figure 1A and Supplementary Table 2). For SFA-dmCpG
and PUFA-dmCpG, the relative proportions of negative and
positive associations with DNAm (i.e., hypomethylated and
hypermethylated, respectively) were opposite between prandial
states, whereas MUFA-dmCpG were mostly hypomethylated
in either prandial state (Figure 1A). MUFA-dmCpG profiles
mirrored that of BMI-dmCpG in FS, while neither SFA, nor
MUFA, nor PUFA-dmCpG profiles mirrored PS BMI-dmCpG.
However, SFA and PUFA profiles showed opposite tendencies
in either prandial state. Functional analysis revealed that SFA-
dmCpG-harboring genes were significantly enriched for targets
of nuclear factor kappa B (NFκB), a master regulator of the
inflammatory response (FDR < 0.007) (Lawrence, 2009).
As for dmCpG overlap between FA saturation groups, 53% of
SFA-dmCpG were specific to that group. Conversely, the majority
of MUFA-dmCpG and PUFA-dmCpG were shared with one
and/or the other saturation group (Figure 1B). For example, 90%
and 79% of MUFA-dmCpG and PUFA-dmCpG, respectively,
overlapped with other saturation groups. In particular, in either
prandial state highest and lowest overlap was between SFA-
dmCpG and PUFA-dmCpG and SFA-dmCpG and MUFA-
dmCpG, respectively. Notably, for the former the direction of
association was negative, while the latter showed a positive
association. A total of seven and five dmCpG overlapped in all
three saturation groups in FS and PS, respectively. Of these, two
were located within regulatory regions, i.e., in SETDB1 in FS
and LASS3 in PS. In either gene, CpG methylation correlated
negatively with SFA and MUFA but positively with PUFA, akin
to the previously published associations between FA saturation
and global DNAm (de la Rocha et al., 2016).
To understand whether dmCpG of a given saturation group
were representative of all individual FA-dmCpG within that
group, we probed for associations between CpG methylation
values and individual SFA, MUFA, and PUFA (three, four, and
eight FA, respectively). Individual FA-dmCpG count ranged
between 2 and 58 in FS and between 0 and 32 in PS, with
EDA and C16:1 being associated with most and least dmCpG,
respectively. PA, C20:1, EDA, and EPA were associated with most
dmCpG within SFA, MUFA, n-6, and n-3 PUFA, respectively
(Supplementary Table 3 and Supplementary Figure 2). As
observed for BMI and FA saturation groups, individual FA-
dmCpG were significantly more abundant in FS than in PS
(average FS/PS ratio = 3.5; p = 0.009), with only a minority
shared between prandial states, i.e., 5 and 12% in FS and
PS, respectively. With a few exceptions (C14:0, C18:0, AA,
C22:4n-6), individual FA showed opposite associations with CpG
methylation in FS and PS (Supplementary Figure 2). Within
each saturation group, dmCpG profiles were consistent across
individual PUFA with the exception of AA but heterogeneous
across individual SFA and MUFA. However, the most abundant
individual FA in blood of each group based on percentage (OA,
PA, and linoleic acid, respectively) largely mirrored the overall
methylation associations of each saturation group, with the
exception of OA in PS (compare Figure 1A and Supplementary
Figure 2). In FS, we corroborated the previously documented
tendency of EPA and EA to elicit hypermethylation and the
hypomethylating effect of OA (de la Rocha et al., 2016; Flores-
Sierra et al., 2016). Notably, the limited dmCpG overlap between
the MUFA isomers OA and EA is in line with their previously
reported divergent effects on DNAm (Flores-Sierra et al., 2016).
Indeed, the paucity of shared dmCpG within a saturation
group compared to dmCpG shared among saturation group
was particularly obvious for SFA-dmCpG and MUFA-dmCpG,
i.e., overlap within those saturation groups was on average
3% (Supplementary Figure 3 and Supplementary Table 3)
but ∼4–5-fold higher across saturation groups (15 and 12%,
respectively; p < 0.01 in either case, Mann–Whitney U-test)
(Supplementary Table 4). PUFA-dmCpG followed a different
trend, as overlap either within PUFA or with SFA/MUFA groups
was comparatively high (27 and 14%, respectively; p > 0.05).
No significant functional enrichment was detected of
individual FA-dmCpG-harboring genes, and none overlapped
with loci associated with n-3 PUFA intake in EWAS (Aslibekyan
et al., 2014). However, several FA-dmCpG mapped within
promoter regions of pathobiologically relevant genes. All
were prandial state-specific, with the exception of dmCpG in
DTX2 and LCLAT1, and several were shared across individual
FA from different saturation groups (Table 2). Furthermore,
we uncovered some general patterns with respect to the
direction of association across individual FA from distinct
saturation groups: (1) an opposite direction between SFA PA-
dmCpG on the one hand, and MUFA C20:1-dmCpG and
individual PUFA-dmCpG on the other, and (2) a concordance
between SFA PA-dmCpG and MUFA OA-dmCpG. For each
of these FA, the described associations mirrored their overall
dmCpG profiles (Supplementary Figure 2). The most notable
prandial state-specific profile was a 10-dmCpG region in
the 5′ region of LHX6, encoding a pleiotropic DNA-binding
protein that controls craniofacial development (Zhou et al.,
2015; Table 2). These 10 dmCpG (collectively referred to as
dmLHX6) were specific for FS C20:1-dmCpG, EDA-dmCpG,
and DGLA-dmCpG and overlapped with the binding sites of
the transcriptional regulator EZH2 (chromosome 9:124,987,559–
124,990,236), which is implicated in adipogenesis, among
other phenomena (Wang et al., 2010). Interestingly, three
dmLHX6 CpG—cg04282082, cg13571460, and cg21469772—
were hypermethylated, albeit only by 3–5%, in human monocytes
stimulated with increasing AA doses in the 1–10-µM range
(Silva-Martínez et al., 2016). The PUFA AA was associated with
dmLXH6, although significance was lost after correcting for cell
type composition. Therefore, the associations of dmLHX6 with
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TABLE 2 | Selected 5′ region dmCpG associated with multiple FA.
Gene, CpG ID FA, association r Relevance
SFA MUFA PUFA
FS PS FS PS FS PS
CBLN1 Highly expressed in adipose tissue,
lipid-binding activity (Ye et al., 2020)













DTX2 Notch signaling (Kishi et al., 2001)






cg06619150 PA, 0.59 C20:1, −0.59 AA, −0.71
DHA, −0.64
HIVEP3 Inflammation (Hicar et al., 2001; Oukka
et al., 2002)
cg11769885 EPA, −0.66
cg23762517 PA, 0.59 PA, 0.58 OA, 0.60 EPA, −0.73 EDA, −0.65
cg26038582 PA, 0.63 OA, 0.65 EPA, −0.73
LCLAT1 Cardiac homeostasis (Bravo-San Pedro
et al., 2017)
cg15652532 C20:1, 0.70 EDA, 0.60 EDA, 0.67
DGLA, 0.69
LHX6 Craniofacial development (Zhou et al.,
2015)
cg00142257 C20:1, 0.64 EDA, 0.58
cg03363289 C20:1, 0.60
cg04282082 C20:1, 0.69 EDA, 0.68
cg05037505 C20:1, 0.84 EDA, 0.78
DGLA, 0.61
cg05136264 C20:1, 0.65 EDA, 0.62
cg11479503 C20:1, 0.70 EDA, 0.71
C22:4n-6, 0.66
DHA, 0.87
cg13571460 C20:1, 0.74 EDA, 0.78
C22:4n-6, 0.73
DHA, 0.85
cg13862711 C20:1, 0.67 EDA, 0.66
cg15124400 C20:1, 0.80 EDA, 0.76
C22:4n-6, 0.61
cg21469772 C20:1, 0.70 EDA, 0.74
C22:4n-6, 0.64
MIR487B Ischemia, vascular remodeling (Nossent
et al., 2013; Van Der Kwast et al., 2018)
cg18863119 PA, −0.71 C20:1, 0.58 EDA, 0.76
DGLA, 0.63
MIR539 Heart failure (Muthusamy et al., 2014)
cg14667980 PA, −0.64 C20:1, 0.58 EDA, 0.68
DGLA, 0.62
POU2AF1 (OCAB) Brown fat tissue accumulation, insulin
resistance (Carter et al., 2018)
cg24049888 C20:1, 0.76 EDA, 0.68
DGLA, 0.61
SETDB1 Regulation of chromatin, lipid storage
(Zheng et al., 2018)
cg10589385 PA, −0.66 AA, 0.64 EPA,
0.62 C22:4n-6,
0.79
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C20:1, EDA, and DGLA are likely causal. Another notable case
are dmCpG within HIVEP3 or Schnurri-3, encoding a ligand
of the kappaB enhancer motif that regulates the inflammatory
response, which were positively associated with PA and OA
but negatively with selected PUFA (Hicar et al., 2001; Oukka
et al., 2002; Supplementary Table 3, Table 2). Interestingly,
we previously found that HIVEP3 cg23762517 and cg26038582
methylation correlated inversely with expression in THP-1
cells stimulated with OA in the 1–10-µM range (r = −0.61;
Affymetrix Human Exon 1.0 ST data and 450K data), thus
mirroring the positive association of OA with HIVEP3 promoter
dmCpG observed here (Silva-Martínez et al., 2016). Additional
dmCpG in regulatory regions of pathobiologically relevant genes
included PA-dmCpG within the ACBD5 that is involved in long-
chain FA metabolism (Ferdinandusse et al., 2017); CD34, an
adipocyte progenitor marker (Hui et al., 2007); and CDH18
that hosts variants associated with the metabolic syndrome
(Zhang et al., 2013). Importantly, the previously documented
associations of FA with PDK4 and HDAC4 regulatory regions in
AMM (de la Rocha et al., 2016) showed the same tendency as
previously observed (de la Rocha et al., 2016), albeit none of the
corresponding dmCpG passed the calling filter. Taken together,
the data indicate that associations of FA with DNAm are better
captured by analyzing individual FA rather than FA grouped
by degree of saturation, in particular of SFA and MUFA. Also,
experimental data sets support a causal role for FA at least in the
case of LHX6 and HIVEP3 promoter dmCpG.
Comparison Between BMI and Individual
FA-Associated DNAm Profiles
A general comparison of the associations with CpG methylation
in FS and PS identified a number of patterns. Firstly, prandial
state-associated BMI-dmCpG were ∼2–35-fold more abundant
compared to individual FA-dmCpG. Shared dmCpG between FS
and PS as percentage of PS dmCpG followed a similar trend (BMI:
36.6%; all FA: average 10.5%) (Figure 1A and Supplementary
Figure 2). Secondly, dmCpG tended to be shared between BMI
and FA more frequently in FS compared to PS. For example,
the SFA PA-dmCpG, MUFA C20:-dmCpG, PUFA EDA-dmCpG,
and DGLA-dmCpG were shared between BMI and FA on average
∼10-fold more frequently in FS compared to PS (16.0% and 1.5%
of the corresponding FA-dmCpG, respectively; p = 1.9 × 10−11,
Chi-square test) (Figure 2). Of note, these particular FA were
chosen based on an arbitrary threshold of > 15 dmCpG in
each prandial state for statistical robustness. Also, pathobiological
relevance has also clearly been established for some of those FA:
PA is a proinflammatory FA that induces DNA hypermethylation
in cultured cells (Barrès et al., 2009; Hall et al., 2014), and
EDA can be converted to AA and DGLA, two precursors of
inflammation modulators (Brenner, 1974; Huang et al., 2011).
Thirdly, dmCpG were shared to a lesser extent between BMI
and FA than across FA in FS (16.0% and 41.6%, respectively;
p = 0.044, Mann–Whitney U-test) and even more markedly so
in PS (1.5% and 63.1%, respectively; p = 7.9 × 10−7) (Figure 2).
This trend was also observed when all FA were considered in
PS (BMI-dmCpG and FA-dmCpG overlap, 7.5%; overlap across
FA-dmCpG, 18.2%; p = 0.029) but not in FS (Supplementary
Table 4). A list of overlapping BMI-dmCpG and FA-dmCpG
located within promoter regions is shown in Table 3. Of note,
the directions of association with BMI were discordant with the
MUFA C20:1 and the PUFA EDA and DGLA, but concordant
with the SFA PA. A further notable example is six ZNF718
dmCpG positively associated with BMI (Table 1) but negatively
with linoleic acid (Supplementary Table 3).
To further compare prandial state-related features of CpG
methylation associations with BMI and FA, we determined the
genomic distributions of dmCpG relative to gene compartments
and CpG islands. In the latter distribution, the genome is divided
into CpG islands, shores (2-kb regions adjacent to either side
of a CpG island), shelves (2-kb regions adjacent to shores,
on either side of a CpG island), and open sea (rest of the
genome). CpG islands are mostly unmethylated regions that
can undergo hypermethylation in aging and atherosclerosis,
while aberrant methylation of shores has been linked to cancer
(Issa et al., 1994; Irizarry et al., 2009; Castillo-Díaz et al.,
2010). With respect to individual FA, we restricted the analysis
to the aforementioned FA that had > 15 dmCpG in either
prandial state (i.e., PA, C20:1, EDA, and DGLA). Supplementary
Figure 4 shows a summary of dmCpG distributions and their
comparisons with either the 736,741 Infinium methylation EPIC
array reference probes, between FS and PS, or among dmCpG
sets. In either prandial state, BMI-dmCpG distribution relative
to gene compartments or CpG islands was not significantly
different from the distribution of the array reference probes.
Conversely, all FA-dmCpG—with the exception of FS C20:1-
dmCpG—differed from reference probe distribution in the
majority of cases, with stronger significance in PS relative
to FS. FA-dmCpG and BMI-dmCpG distribution across gene
compartments was more similar in FS than in PS. Likewise, only
FA-dmCpG distribution differed significantly across prandial
states. Also, across FA-dmCpG, 5′-regulatory regions were
more frequent in PS compared to FS (p < 10−6), but CpG
islands were less represented (∼1.4–1.6-fold; p < 0.01). In all
cases, CpG islands were mostly outside promoters (gene bodies
and intergenic).
Next, we asked whether dmCpG were differentially distributed
among quartiles of β-values in N samples. The rationale for this
analysis was that regulatory regions across the genome display
characteristic DNAm levels. In particular, partially methylated
regions are prone to dynamic changes in DNAm in response to
regulatory DNA-binding proteins and undergo global changes
in cancer (Stadler et al., 2011; Berman et al., 2012). In both FS
and PS, BMI-dmCpG were most abundant in N sample upper-
intermediate β-values (0.5–0.75) and did not significantly differ
between FS and PS (Supplementary Figure 5). Interestingly, 15
out of 16 CpG island BMI-dmCpG had β > 0.25 (average: 0.57;
range: 0.29–0.76) in FS N samples, and the majority (11 out of 16)
underwent further hypermethylation with increasing BMI. In PS,
that pattern was less obvious, as ∼50% of CpG island dmCpG
were highly methylated in N samples. With respect to specific
FA, PA-dmCpG and EDA-dmCpG were significantly different
between FS and PS, tending to be shifted toward intermediate-
low β in PS (p = 1.1× 10−5 and p = 7.8× 10−9, respectively).
Frontiers in Genetics | www.frontiersin.org 7 May 2021 | Volume 12 | Article 665769
fgene-12-665769 May 3, 2021 Time: 17:2 # 8
Pescador-Tapia et al. Prandial State-Associated DNA Methylation Profiles
FIGURE 2 | Shared dmCpG between BMI and FA. Percentage of shared
dmCpG between BMI and FA, or among FA in FS (solid bars) and PS (open
bars). Percentages were calculated of FA dmCpG counts in BMI-FA
comparisons, or of the lowest dmCpG counts in FA-FA comparisons. FS and
PS, fasting and postprandial state, respectively. Significance of differences
between the percentage of dmCpG shared by BMI and FA and shared by FA
is shown in FS and PS (Mann–Whitney U-test).
The Prandial State Exerts BMI
Class-Specific Effects on DNAm Profiles
Finally, we sought differential DNAm between FS and PS.
To that end, we compared CpG methylation profiles within
each of the three BMI classes—i.e., N in FS against N in PS,
and the corresponding comparisons for Ow and Ob. In this
case, dmCpG were called when the difference between average
β > 0.10 and M-value paired comparison p < 0.05. Strikingly,
the comparison between Ow yielded a total of 139 dmCpG (Ow-
dmCpG), whereas the comparisons between N and between Ob
yielded only two and one dmCpG, respectively (Figure 3A). The
dmCpG list is provided in Supplementary Table 5. This large
difference in dmCpG counts could result either from peculiar
characteristics of the overall Ow dataset or from nonbiological
factors such as sample handling or microarray technical issues.
Yet, the comparison between Ow and N or between Ob and N in
either FS or PS yielded predictable profiles, i.e., dmCpG counts
were ∼2-fold larger in the Ob-N comparison relative to Ow-N
in FS and were similar in the two comparisons in PS—i.e., no
excess dmCpG count was observed in Ow (Figure 3B). DmCpG
were identified by the same filtering criteria as above (p < 0.05
in M value comparisons, 1β > 0.10 between Ow or Ob and
N). Also, the extent of differential methylation as measured by
average 1β was similar across comparisons and indeed lower
in the Ow-N comparison relative to Ob-N in PS (0.11 ± 0.02
and 0.14 ± 0.06, respectively; p = 0.016). Furthermore, BMI was
not more variable in Ow: SD expressed as percentage of average
increased with BMI and was 1.4, 5.7, and 8.8 in N, Ow, and Ob,
respectively, in FS. The same trend was observed in PS: 4.6, 5.7,
and 9.1, respectively. Furthermore, as a possible explanation for
the distinct behavior of Ow-dmCpG, we sought associations of
the 139 Ow-dmCpG with all available metabolic (triglycerides,
cholesterol, lipoproteins, glucose), somatometric (height, waist
and hip circumference), and vascular (systolic and diastolic blood
pressure) parameters. No significant association was detected
in any case. We conclude that the observed difference between
FS and PS Ow is specifically imposed by the combination of
prandial state and BMI class, although the underlying mechanism
is unclear. Notably, Ow-dmCpG-hosting genes were significantly
enriched in targets of known transcription factors involved in
lipid metabolism and obesity (p < 0.05, FDR; Supplementary
Table 6). No overlap of Ow-dmCpG-hosting genes with any of
the published studies indicated above was observed.
Ow-dmCpG showed a slight trend toward hypomethylation
in PS relative to FS (81 of 139 Ow-dmCpG or 58.3%). Ow-
dmCpG genomic distribution relative to gene compartments or
CpG islands was significantly skewed in favor of promoters and
first exons (∼1.8-fold enrichment, p = 0.006; Chi-square test)
and CpG islands (∼2.3-fold, p = 9.7 × 10−8), where enrichment
TABLE 3 | Promoter dmCpG associated with BMI and FA.
Gene, CpG ID Association r Relevance
BMI PA C20:1 EDA DGLA
FS PS FS PS FS PS FS PS FS PS
CRISP2 Associated with atherosclerosis (Istas et al., 2017)
cg01076129 −0.85 −0.76 0.62 0.80
cg14997592 0.61 0.64
cg15509430 −0.73 −0.59 0.70
cg25390787 0.68 0.62
cg26715042 −0.70 −0.83 0.76 0.69
cg12440062 −0.79
ESPNL Marker of alcohol exposure (Clark et al., 2018)
cg15871206 0.61 −0.69 −0.66
cg19391697 0.60
ZNF260 Elevated in hypertension (Debrus et al., 2005)
cg06920214 −0.82 −0.69 0.62 0.71
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FIGURE 3 | Overview of prandial state-induced and BMI category-associated DNA methylation changes. (A) Within each BMI class in PS relative to FS. (B) Across
BMI classes. Solid and open bars, hypermethylated and hypomethylated, respectively. The number above each bar indicates the average absolute 1β. N, Ow, and
Ob, normoweight, overweight, and obese, respectively. *, p < 0.05. t-test between M-values.
was highest of any dmCpG set, compared to the distribution of
the 736,741 Infinium methylation EPIC array reference probes
(Supplementary Figure 4). That enrichment was contributed to
by the Ow-dmCpG fraction that was hypermethylated in PS,
which was ∼4.5-fold enriched in CpG islands (p = 8.7 × 10−67)
and ∼5-fold in promoters, while ∼3-fold and ∼21-fold
depleted in gene bodies and intergenic regions, respectively
(p = 2.9 × 10−53), compared with the hypomethylated fraction.
Ow-dmCpG distribution was significantly different from BMI-
dmCpG and any FA-dmCpG, either in FS or PS. Distribution
across FS β quartiles was highly skewed toward unmethylated or
very low methylation regions for hypermethylated Ow-dmCpG
but peaked in the middle-high methylation β quartile (0.5-
0.75) in the case of the hypomethylated set (Supplementary
Figure 5). Since 79.1% of promoter/5′UTR/first exon and 82.4%
of CpG island Ow-dmCpG had β < 0.5 in FS, we conclude
that hypermethylation of the promoter and CpG island with low
baseline methylation was a distinct feature of Ow-dmCpG. No
shared dmCpG among the three PS-to-FS comparisons, with BMI
or FA, was observed.
The above data suggest that the postprandial dynamic
remodeling of DNAm in Ow might establish Ob-specific
epigenetic profiles upon transition from overweight to obesity.
To assess that hypothesis, we examined the β-values of four
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promoter dmCpG mapping to relevant genes and with the
highest absolute 1β between PS and FS Ow, across BMI classes.
The data indicated a larger variability in Ow compared to N or
Ob. However, no Ob-specific profile could be observed, as N and
Ob profiles were indistinguishable (Figure 4).
DISCUSSION
We reveal for the first time two distinct associations among
prandial state, BMI, FA, and CpG methylation in human
peripheral blood. Firstly, the associations of CpG methylation
with BMI and FA differ in fasting and postprandial states, in terms
of number and identity of targeted CpG, and direction of CpG
methylation change. Also, BMI-dmCpG and most FA-dmCpG
are more numerous in FS relative to PS. Secondly, the number
of dmCpG between prandial states within the same BMI class is
dramatically different among BMI classes.
Comparisons of associations with BMI and with FA reveal that
BMI-dmCpG are more abundant than FA-dmCpG, when either
prandial state-specific or shared between prandial states dmCpG
are considered. These observations underline the relevance
of the BMI, either as causal factor or covariable, for the
epigenome. The paucity of shared dmCpG also indicates that
associations of BMI and FA are mechanistically distinct. This
conclusion is reinforced by the observation that BMI-dmCpG
and FA-dmCpG map to genomic regions with distinct baseline
methylation levels and positions relative to CpG islands or gene
compartments: BMI-dmCpG are not significantly enriched in
any genomic context and have mostly intermediate–high baseline
methylation level. Conversely, PA-dmCpG and EDA-dmCpG are
in distinct baseline methylation level bins in FS and PS, and
FIGURE 4 | DNA methylation trend in fasting and postprandial states across BMI classes. Open squares and solid circles, fasting and postprandial state,
respectively. Gene name and EPIC array Ow-dmCpG ID are indicated above each graph. N, Ow, and Ob, normal weight, overweight and obese, respectively.
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FA-dmCpG are generally differentially distributed relative to
CpG islands and gene compartments in FS and PS. Also, CpG
island FS BMI-dmCpG, C20:1-dmCpG, and EDA-dmCpG are
highly methylated and undergo further hypermethylation with
increasing BMI or FA. This pattern is unusual, as CpG islands are
mostly unmethylated or methylated at low levels throughout the
genome (Bird et al., 1985; Edwards et al., 2017). Corresponding
PS CpG island dmCpG do not show such polarized features.
Our study design strongly suggests causality of the prandial
state with respect to DNAm, possibly via interaction with
genetics or environmental/dietary variables. Yet, the mechanism
underlying prandial state-specific associations of DNAm with
BMI or FA can only be speculated. BMI and FA might
differentially affect DNAm depending on the postprandial or
fasting metabolic conditions or might be inert covariates of the
causal factor. Our CpG filtering method rules out diet-dependent
blood cell composition effects. Also, it is unlikely that results
were affected by statistical artifacts due to the difference in FA
pool composition between FS and PS (de la Rocha et al., 2016).
Specifically, the paucity of associations in PS could be due to
more homogeneous distributions in that group: yet, taking PA
as example, correlation r is in the −0.85–+0.85 range in FS and
PS. Also, PA tends to increase with BMI and actually does so
more markedly in PS than in FS (105.0% and 57.9% increase
in Ob compared to N, respectively). Additionally, dmCpG were
often specific to FS or PS. In fact, FS and PS shared relatively
few FA-associated DNAm profiles, and a number of dmCpG
switched the direction of associations depending on the nature
of the individual FA, within FS or PS. Another consideration
is that the directions of association were consistent for most
PUFA on the one hand, and for BMI, OA, and PA on the other,
in accordance with the accepted pathophysiological properties
respectively assigned to PUFA and SFA. Notably, the position of
the MUFA OA is ambiguous, as is its association with disease risk
(Steffen et al., 2018).
Distinct patterns emerged also at the individual CpG level. For
some dmCpG, causal effects of BMI or FA on DNAm are strongly
supported either by direct mechanistic data such as dmLHX6
profiles and HIVEP3 expression in cultured cells stimulated with
AA or OA or by independent functional and gene expression
studies of promoter regions of LHX6, ASAH1, MIR487B,
and HIF3A as follows: (1) LHX6 controls embryonic skeletal
development, and the relevance of dmLHX6 is supported by the
known involvement of PUFA and their metabolites in craniofacial
development in animal models (Greene and Garbarino, 1984;
Kay et al., 1988). DmLHX6 are uniquely associated with three C20
FA which are precursors or intermediates of the same metabolic
pathway, thus pointing to specific biological activity. (2) The
negative association of ASAH1 promoter methylation with BMI
is in accordance with higher ASAH1 expression in a mouse
NAFLD model (Presa et al., 2019). (3) Hypomethylation of the
MIR487B promoter with increasing PA, but hypermethylation
with increasing C20:1, EDA, and DGLA, is in agreement
with its previously documented adverse effect of MIR487B on
insulin signaling and upregulation in hypertension in vivo in
a rat model, validated in human cultured cells (Nossent et al.,
2013). 4) Three independent studies including ours consistently
point to the association of HIF3A promoter hypermethylation
with adverse metabolic outcomes such as obesity and insulin
resistance, in omentum of gestational diabetes mellitus patients
and in human peripheral blood cells analyzed by EWAS (Zhang
et al., 2019; Crocker et al., 2020). Another relevant finding is
differential methylation of CRISP2. The data are more difficult
to interpret in this case, as hypermethylation of the CRISP2
promoter CpG cg26715042 in peripheral blood cells is associated
with atherosclerosis, but the opposite association is observed
here with BMI (Istas et al., 2017). It is possible that our data
represent compensatory responses to the establishment of obesity
in metabolically normal subjects, whereas the literature points
to phenomena occurring in metabolically heterogeneous obese
samples. A further caveat is that previous studies were based on
a variety of biological models and may not be readily comparable
with the approach present here. It is therefore not surprising that
our findings did not replicate any of the published BMI or FA
EWAS, with the exception of the Strong Heart Study (Crocker
et al., 2020). A likely reason for those discrepancies is the
specific characteristics of our cohort, particularly its homogeneity
in terms of gender, age, race, occupational and environmental
exposure, and absence of any complication of obesity. Taken
together, several considerations suggest that our findings are
biologically plausible, despite the two main limitations of this
study: small sample size and lack of information on dietary intake
prior to sampling.
In addition to prandial state-specific profiles, our study
uncovered BMI-associated DNAm profiles that overlapped
between FS and PS and thus are testable candidate causal loci of
later complications such as metabolic syndrome, CVD, diabetes,
and fatty liver disease. Of particular interest was the positive
association between promoter methylation of MTHFS and BMI
in FS and PS. Notably, upregulation of MTHFS lowers cellular
folate, an essential cofactor for methylation reactions, which
could potentially explain the inverse correlation between global
DNAm and BMI previously reported in FS and PS (Anguera et al.,
2003; de la Rocha et al., 2016). In that study, we also showed
that in both prandial states SFA and MUFA were inversely
associated with global DNAm, while the opposite was true for
PUFA. Interestingly, SETDB1 promoter methylation mirrored
the above-described associations in FS. SETDB1 is an important
regulator of lipid storage (Zheng et al., 2018), in addition to
being the most important driver of transposon methylation
in embryonic stem cells and somatic tissues. SETDB1 is
upregulated during early embryogenesis when the mammalian
genome undergoes a global hypomethylation event (Fukuda
and Shinkai, 2020). This might suggest that fasting-induced
SETBD1 promoter hypomethylation represents a compensatory
mechanism for transposon silencing during fasting-induced
BMI-dependent global DNA hypomethylation. Furthermore,
the ceramide synthase LASS3 promoter methylation may be
predicted to decrease global DNAm given the recent finding
of the DNA hypermethylating potential of ceramides in PS
(Castro et al., 2019).
Also, the comparison of our previous global DNAm survey
in AMM and the present study reveals differences in association
directions for BMI and FA, particularly in PS. These discrepancies
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suggest a markedly different behavior of repeated and non-
repeated genomic sequences.
Lastly, we demonstrate that the prandial state affects CpG
methylation in a BMI class-dependent fashion. Surprisingly,
dmCpG between PS and FS are vastly more abundant in the
Ow group compared to N and Ob, in addition to showing
relatively high methylation variability. Thus, the combination
of Ow and prandial state generates dmCpG, echoing evidence
that BMI causes DNAm (Sun et al., 2019). Yet, no overlap
with BMI-dmCpG exists. In addition, Ow-dmCpG were enriched
in CpG islands and promoters with low baseline methylation
level that undergo hypermethylation in PS compared to FS, a
distinct pattern in comparison with BMI-dmCpG (see above).
The dynamic epigenetic profiles of Ow likely represent the
initial drift during the transition to obesity, or an adaptation
to overweight. A testable hypothesis is that the intrinsic
Ow epigenetic dynamicity and prandium-induced differential
methylation transiently modifies the expression of critical genes,
thus setting a transcriptional program in motion that proceeds
autonomously once obesity is reached. Ow-dmCpG mapped
to a number of genes involved in obesity and metabolism.
Notable examples were MAP4K2 or GCK, close to an SNP
associated with uric acid and a candidate player in inflammation
(Chuang et al., 2016; Lee et al., 2018); IRX2, associated with
BMI in women and expressed in an adipose tissue depot-
dependent fashion (Karastergiou et al., 2013; Ng et al., 2017)—
IRX2 promotes cellular differentiation in leukemia and could
therefore exert currently unappreciated obesity-related effects
in blood cells, for instance by altering the leukocyte repertoire
(Scalea et al., 2020); KLF3, a driver of diet-induced obesity
in mice which could act by promoting the expression of
the adipose browning factor in selected white blood cells
(Bell-Anderson et al., 2013; Knights et al., 2020); RREB1,
promoting adipose tissue browning (Brunmeir et al., 2016)—
the RREB1-altered expression in peripheral blood is associated
with pediatric obesity (Plaza-Florido et al., 2020); KLHL32,
associated with BMI in a blood-based genome-wide association
study (Monda et al., 2013); PLOD3 (aka LH3), involved in
adiponectin production (Zhang et al., 2015)—peripheral blood
PLOD3 expression is altered in obstructive sleep apnea, a
condition linked to obesity (Perry et al., 2013); and HVCN1,
a driver of reactive oxygen species production in B cells
(Capasso et al., 2010). The most significant enrichment was of
targets for E47, an activator of adiponectin expression (Doran
et al., 2008). E47 regulates hematopoiesis, and its expression in
blood cells could therefore determine to establish obesity-related
lineages (Meyer et al., 2020). Other relevant target enrichments
were for RREB1, which is also encoded by an Ow-dmCpG-
hosting gene, and for SREBP1, a partner of E47 in adiponectin
expression activation and an extensively studied regulator of FA
metabolism (Doran et al., 2008; Jump, 2011). Methylation of
selected SREBP1 CpG is also associated with adiposity (Justice
et al., 2020). Also, SREBP1 has been implicated in establishing
a proatherogenic lipid profile in monocytes (Bowman et al.,
2020). In summary, several of the indicated genes have well-
characterized functions in adipocytes, but evidence for regulation
of blood cell homeostasis supports our differential methylation
data. Based on transcription factor-binding site enrichment
data, E47/SREBP and RREB1 might be master regulators of
Ow-specific transcriptional profiles. In particular, our data
suggest a loop in RREB1 signaling, with reduced RREB1–
target gene interaction, consistent with the enrichment in
hypermethylated promoters, secondary to an increase in RREB1
promoter methylation induced by an unidentified mechanism
in PS. The functional roles for RREB1 and E47 are supported
by their respective documented beneficial effects on adipocyte
browning and adiponectin expression (Doran et al., 2008;
Brunmeir et al., 2016). At any rate, further studies with a
larger sample size are necessary for confirming the observed Ow
epigenetic dynamicity.
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